Gabi Journal-generics And Biosimilars Initiative Journal

Journal Title：Gabi Journal-generics And Biosimilars Initiative Journal

The GaBI Journal Generics and Biosimilars Initiative Journal (GABI J) is an academic journal dedicated to the field of generic drugs and biosimilars. This journal is committed to promoting the research, development, and application of generic drugs and biosimilars, providing an important communication platform for academia and industry.

GABI J is published or managed by Pro Pharma Communications International and is located in Belgium. This journal has been included in authoritative databases such as Emerging Sources Citation Index (ESCI), demonstrating its significant influence in the fields of generic drugs and biosimilars. At the same time, GABI J also provides paper editing, translation, typesetting and other services through platforms such as LetPub, helping global authors publish high-quality research papers smoothly.

《Gabi 期刊-仿制药和生物仿制药倡议期刊》（简称GABI J）是一本专注于仿制药（Generics）和生物类似药（Biosimilars）领域的学术期刊。该期刊致力于推动仿制药和生物类似药的研究、开发与应用，为学术界和产业界提供了一个重要的交流平台。

GABI J由Pro Pharma Communications International出版或管理，出版地位于比利时（Belgium）。该期刊被Emerging Sources Citation Index (ESCI)等权威数据库收录，显示出其在仿制药和生物类似药领域的一定影响力。同时，GABI J还通过LetPub等平台提供论文编辑、翻译、排版等服务，助力全球作者顺利发表高质量的研究论文。

Gabi Journal-generics And Biosimilars Initiative Journal由Pro Pharma Communications International出版商出版，收稿方向涵盖PHARMACOLOGY & PHARMACY全领域，平均审稿速度 ，影响因子指数0.3，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。